TD, tardive dyskinesia; VMAT2, vesicular monoamine transporter 2. * Level A is the strongest recommendation, established as effective, based on at least 2 consistent class I studies. Level B refers to probably effective treatment, derived from at least 1 class I study or 2 consistent class II studies.
